federal_register: E8-21674
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E8-21674 | Medicare Program; Medicare Advantage and Prescription Drug Benefit Programs: Final Marketing Provisions | Rule | This final rule revises the Medicare Advantage (MA) program (Part C) and Medicare Prescription Drug Benefit Program (Part D). The regulation contains new regulatory provisions regarding marketing processes for both programs. The revisions to the Part C and Part D programs are based on lessons we have learned since 2006, the initial year of the prescription drug program and the revised MA program. | 2008-09-18 | 2008 | 9 | https://www.federalregister.gov/documents/2008/09/18/E8-21674/medicare-program-medicare-advantage-and-prescription-drug-benefit-programs-final-marketing | https://www.govinfo.gov/content/pkg/FR-2008-09-18/pdf/E8-21674.pdf | Health and Human Services Department; Centers for Medicare & Medicaid Services | 221,45 | This final rule revises the Medicare Advantage (MA) program (Part C) and Medicare Prescription Drug Benefit Program (Part D). The regulation contains new regulatory provisions regarding marketing processes for both programs. The revisions to the Part C... |